Groundbreaking Developments in Multiple Sclerosis Management
New studies are opening up promising new frontiers in managing MS. Focus is increasingly on medications that not only slow disease progression, but potentially regenerate affected myelin. Cutting-edge methods include new medications modulating specific immune response components and evaluating th